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Background Cancer incidence in exposed rescue/recovery workers (RRWs) and
civilians (non-RRWs) was previously reported through 2008.
Methods We studied occurrence of first primary cancer among World Trade Center
Health Registry enrollees through 2011 using adjusted standardized incidence ratios
(SIRs), and the WTC-exposure-cancer association, using Cox proportional hazards
models.
Results All-cancer SIR was 1.11 (95% confidence interval (CI) 1.03–1.20) in RRWs, and
1.08 (95% CI 1.02–1.15) in non-RRWs. Prostate cancer and skin melanoma were
significantly elevated in both populations. Thyroid cancer was significantly elevated only
in RRWs while breast cancer and non-Hodgkin’s lymphoma were significantly elevated
only in non-RRWs. There was a significant exposure dose-response for bladder cancer
among RRWs, and for skin melanoma among non-RRWs.
Conclusions We observed excesses of total and specific cancers in both populations,
although the strength of the evidence for causal relationships to WTC exposures is
somewhat limited. Continued monitoring of this population is indicated. Am. J. Ind. Med.
59:709–721, 2016.  2016 Wiley Periodicals, Inc.
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INTRODUCTION
The attacks of September 11, 2001, on the World Trade
Center (WTC) in New York City (NYC) resulted in collapse
of the WTC office towers, and an immense cloud of dust and
debris that exposed hundreds of thousands of individuals to
numerous hazardous substances, including known carcino-
gens such as asbestos, silica, polycyclic aromatic hydro-
carbons (PAHs), benzene, heavy metals (e.g., cadmium,
lead), as well as polychlorinated biphenyls (PCBs) [NIOSH,
2011, 2012; Lauby-Secretan et al., 2013].
Because of the fine particulate composition of the dust,
combustion products from fires or burning, and the physical
forces resulting in its dispersion in the area surrounding
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“Ground Zero” [Lioy et al., 2002, 2006; Landrigan et al.,
2004] many individuals experienced intense exposures
within the dust cloud and immediately afterwards, less
intense exposures over a protracted period of time, or a
combination. Rescue and recovery workers were potentially
highly exposed between September 11, 2001, and termina-
tion of the cleanup in July, 2002, particularly during the
immediate response. Half of the workers wore no respiratory
protection on the 1st day of response and another one-third
wore unrated disposable masks only [Antao et al., 2011].
Thousands of others continued to either inhabit residences
and/or work near Ground Zero, or else evacuated and
then returned to buildings that underwent prolonged, and
sometimes incomplete decontamination.
Previously we reported excess incidence of multiple
myeloma, prostate, and thyroid cancer among rescue/recovery
workers during 2007 through 2008 [Li et al., 2012]. Increased
cancer incidence has also been reported in two cohorts of
exposed responders followed through 2008 [Zeig-Owens
et al., 2011; Solan et al., 2013]. While total cancer rates were
not significantly greater than expected in any of these studies
[Zeig-Owens et al., 2011; Li et al., 2012; Solan et al., 2013],
each reported a significant increase for at least one site-
specific cancer [Boffetta et al., 2016]. All three cohorts
reported a significant two- to threefold increase in thyroid
cancer. Comparable increases in prostate cancer incidence
were reported by the Fire Department of New York (FDNY)
and theWorldTradeCenterHealthRegistry (WTCHR) [Zeig-
Owens et al., 2011; Li et al., 2012]. A deficit of lung cancer
cases was reported in all three cohorts. However, no excess
cancers were reported among community members not
involved in rescue/recovery [Li et al., 2012]. A recent study
of NYC Police Department personnel compared incidence
rates before and after 9/11, and reported a 44% increase in the
overall median age-adjusted incidence rate for total cancers as
well as some cancer sites; however, the association between
WTC exposure and subsequent cancer development was not
examined [Kleinman et al., 2015].
In this report, we continued evaluating possible excess
cancer among WTCHR enrollees with three additional years
of follow-up, allowing for up to 10 years of latency since the
initial exposures, which is important for assessing a possible
link to cancer. We recalibrated the definition of WTC
disaster physical exposures emphasizing exposure to poten-
tial contaminants containing carcinogens as a result of the
9/11 attacks and aftermath [Landrigan et al., 2004].
MATERIALS AND METHODS
Study Population
Details of the WTCHR have been published else-
where [Farfel et al., 2008; Brackbill et al., 2009]. Briefly,
in 2003–2004 a total of 71,431 persons enrolled by
completing a telephone (95%) or in-person (5%) inter-
view. Participants were either identified through lists
provided by employers, government agencies, and other
entities (30%) (“list-identified”), or they responded to an
outreach campaign (70%) (“self-identified”) and were
enrolled if eligible. Coverage of the eligible exposed
population was estimated at 34% of rescue/recovery
workers and 26% of residents [Murphy et al., 2007]. This
analysis included enrollees who lived in any of the 11
states selected for cancer registry linkage (New York,
New Jersey, California, Connecticut, Florida, North
Carolina, Massachusetts, Ohio, Pennsylvania, Texas,
and Washington) from September 11, 2001 through
December 31, 2011; 91% of enrollees lived in these
states during the follow-up period. Enrollees had to be at
risk for a first primary invasive cancer, defined as never
having had a primary invasive cancer documented in any
of the 11 state cancer registries.
We assumed, as in our previous report [Li et al., 2012],
that any exposure-related cancers would be more likely to
emerge at least 5 years after 9/11. The present analysis
focused on cancers occurring from 2007 through 2011,
restricted to enrollees alive on January 1, 2007 and at risk for
a first primary invasive cancer or in situ bladder cancer.
Enrollees with unknown ethnicity or unclassifiable race were
excluded because reference cancer rates are not available.
The study was approved by the Institutional Review
Board (IRB) of the NYC Department of Health and Mental
Hygiene. Each cancer registry record linkage was also
approved by the respective IRB of 10 state departments of
health and the Rutgers University in New Jersey. A Federal
Certificate of Confidentiality was obtained, and oral
informed consent was obtained from participants at
enrollment.
Outcome Ascertainment
An incident cancer case in our study was a first primary
invasive cancer or in situ bladder cancer that had been
reported to any of the 11 cancer registries and diagnosed any
time post-enrollment through 12/31/2011, the last date for
which complete cancer incidence records were available.
Cancer site was defined using the Surveillance, Epidemiol-
ogy, and End Results (SEER) site recode International
Classification of Diseases for Oncology, Third Edition
(ICD-O-3) groupings, in which categories are based on
primary site and histology of cancer [NCI, 2003].
WTC Exposure and Covariates
Demographic and exposure data were obtained at Registry
enrollment. Enrollees were divided into rescue/recovery
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workers (RRW), and civilians or enrollees not involved in
rescue/recovery (non-RRW). RRW were first responders,
volunteers, and others who worked at the WTC site, debris
loading sites or transport barges, or at the Staten Island
landfill between September 11, 2001 and June 30, 2002. Non-
RRW were residents, children, and staff in schools
(pre-kindergarten-12th grade) south of Canal Street, area
workers and passersby south of Chambers Street on 9/11 in
lower Manhattan. Individuals who were in both groups were
categorized as RRW.
We defined WTC exposures separately for RRW and
non-RRW by focusing on environmental exposures at the
WTC site, and lower Manhattan (see Table SI). Among
RRW, a WTC exposure matrix was created based on date of
arrival, duration of work at the site, dates or time period
working on the pile, and being near theWTC site or exposure
to dust/debris resulting from the collapse of buildings on
9/11. Amodified Delphi Technique [Hasson et al., 2000] was
used to arrive at component weighted scores for each
exposure item. A scale of 1 (lowest) to 10 (highest) was
assigned to each exposure item by a panel of industrial
hygienists and occupational disease epidemiologists, and the
final set of scores was used to compute a mean score for each
item. The sum of WTC exposure scores for each individual
rescue/recovery worker was analyzed both as a continuous
variable (actual sum scores, and natural log transformed to
reduce skew) for trend and as an ordinal scale variable for
analysis of cancer risk at each exposure quartile. The latter,
based on quartiles of the summed points, categorized as: low
(Q1 <25%), intermediate (Q2 25 to <50%), moderate high
(Q3 50 to 75%), and high (Q4 >75%).
For non-RRW, WTC exposure was grouped hierar-
chically into four levels based on the enrollee’s eligibility
category (local residents as the most exposed group,
followed by area workers, passersby, and school staff/
students) [Brackbill et al., 2009], combined with qualitative
exposure data (see Table SII). High exposure level applied to
residents who did not evacuate or who returned home within
the first 30 days after being evacuated on 9/11, and who also
reported exposure to the dust/debris cloud on 9/11. Low
exposure (level 1) was assigned to persons who were not
exposed to the dust/debris cloud, were not residents, and did
not return to a lower Manhattan workplace if they were area
workers or were not present at school on 9/11 if they were
school staff/students.
Covariates included age, sex, race, and ethnicity, along
with measures reported at enrollment: education; household
income; smoking status; enrollment source; and history of
asthma, cardiovascular disease, stroke, emphysema, or diabetes.
Statistical Analyses
RRW and non-RRW generally experienced different
exposures and had very different demographic characteristics,
and were therefore, analyzed separately in external and
internal comparisons as explained below.
External Comparisons
To assess whether the number of cancer cases in the
exposed population was greater or less than expected, we
compared each group to the NewYork State (NYS) population
using the standardized incidence ratio (SIR). The observed
cancer cases were the sum of first primary incident cancers
diagnosed during the period of 2007 through 2011. Expected
cancer cases were determined from the NYS cancer rates and
person-years of follow-up during 2007–2011, adjusted for age
(5-year groups), race/ethnicity, sex, and calendar period
(2007–2011). Race/ethnicity included non-Hispanic white,
non-Hispanic black, Asian, Hispanic, and American Indian or
Alaska Native. Rates from the NYS general population were
used to calculate the number of cancer cases that would have
been expected in the study population had they developed
cancer at the NYS rate. The NYS cancer rates were chosen as
the reference rate because NYS residents account for 86% of
our study population. The NYS cancer rates used in these
analyses were customized by NYSDepartment of Health to be
comparable to our data based on stratification by age, sex, race/
ethnicity, and study period. Person-years of observation for
each participant beganon January1, 2007 and endedon thedate
of the first primary cancer diagnosis, death, withdrawal, or
December 31, 2011, whichever came first. The number of
expected cases was the sum of stratum-specific expected
numbers of cancer cases that were products of stratum-specific
rates and person-years. The 95% confidence intervals (CI) for
SIRs were calculated using Byar’s approximation to the exact
Poisson distribution [Breslow and Day, 1987]. All SIR
computations were performed using MP-SIR sessions of
SEERSTAT software (seer.cancer.gov/seerstat, version
7.0.5).
Finally, cancer rates based on the NYS population may
not be generalizable to the other 10 states. To remove a
possible source of under-representation we repeated the
analyses, limiting the study population to enrollees residing
continuously within NYS (n¼ 44,892; 18,171 RRW; and
26,721 non-RRW). A further sensitivity analysis was
performed in enrollees residing in NYC compared to the
NYC population.
Internal Comparisons
Comparisons among exposure groups were examined
using Cox proportional hazards models separately for RRW
and non-RRW participants. First, the cancers with signifi-
cantly elevated SIRs in the study period were examined.
Second, hematological cancers, which include myeloma,
leukemia, and lymphoma, were examined as each has
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potentially shorter latency period compared to solid tumors,
and thus, might be more likely to show an early increase.
Third, lung cancer and bladder cancer were examined
because carcinogens such as silica, asbestos, PAHs, and
cadmium, detected in measurable quantities at the WTC site
have been associated with both cancers.
Violation of the proportional hazards assumption was
tested by including time dependent covariates in the Cox
model and indicated by their significance. Hazard ratios (HR)
and 95% confidence intervals were adjusted for age at
enrollment, sex, race/ethnicity, smoking, education, income,
and history of a serious non-malignant medical condition as
described above. Enrollment source (self- vs. list-identified)
was included in multivariate analyses to control for potential
selection bias.
Assessing Potential Medical Screening
Bias
Individual cancer screening practice may introduce
bias in the number of observed cancer cases. Lacking data
on medical screening of participants, we indirectly
assessed potential screening bias by comparing the
proportion of localized cancers in our sample to that in
the NYS general population based on the same inclusion
criteria (i.e., NYS residents, the same time period of
2007–2011, age 20 years at diagnosis, and availability
of race/ethnicity and stage), on the assumption that
screening-detected cancers are more likely to be localized
cancers. We focused on prostate, thyroid, and female
breast cancers widely thought to be over-diagnosed
through screening [Welch and Black, 2010]. Proportions
were compared using Pearson’s chi-squared test.
All descriptive and multivariate analyses were per-
formed using SAS software (SAS Institute, Cary, NC,
version 9.2). Significance was set at P< 0.05 (two-sided).
RESULTS
Baseline Characteristics
The 60,339 enrollees (24,863 RRWs and 35,476 non-
RRWs) meeting inclusion criteria for external comparison
accounted for 84.5% of the cohort. After excluding 981
enrollees with unknown WTC exposure data, 59,358
enrollees remained for internal comparison (24,170 RRWs
and 35,188 non-RRWs) (Fig. 1).
Table I shows characteristics of the study population by
RRW status. Median age at enrollment was 42.0 years for
RRW and non-RRW. RRWs were predominantly male
(79.8%), non-Hispanic white (71.2%), and in households
with income of $50,000 to<$150,000 (61.9%) at enrollment.
Among non-RRWs, 46.9% were males, 57.9% non-Hispanic
white, and 40.2% had annual household income of $50,000 to
<$150,000 at enrollment.
Cancer Incidence Among RRWs
Of 24,863 eligible RRWs for external comparison using
SIR, 685 first primary incident cancer cases were identified
during 2007–2011, with an accumulated 120,876 person-
years of follow-up. Median age at diagnosis was 57 years
(range: 28–82 years).
RRW had increased cancer incidence of all cancer sites
combined that was significantly different from that in the
reference population (SIR 1.11, 95% CI¼ 1.03–1.20)
(Table II). Site-specific analyses showed 3 of the 24 cancer
sites with significantly elevated SIR: prostate (#observed
223, SIR 1.43, 95% CI 1.25–1.63), thyroid (#observed 37,
SIR 1.79, 95% CI 1.26–2.47), and skin melanoma
(#observed 37, SIR 1.49, 95% CI 1.05–2.06).
FIGURE1. Selection of study population.
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TABLE I. Characteristics of Study Enrollees by Rescue/Recovery Worker Status,WTCHR (N¼ 60,339)
Rescue/recovery workers
(RRW) (n¼ 24,863)
Enrollees not involved in rescue/recovery
(non-RRW) (n¼ 35,476)
# % # %
Source of enrollment
List-identified 8,418 33.9 8,523 24.0
Self-identified 16,445 66.1 26,953 76.0
Age at enrollment, years
<20 71 0.3 2,797 7.9
20^34 5,204 20.9 7,883 22.2
35^44 9,412 37.9 8,973 25.3
45^64 9,684 38.9 13,963 39.4
65 492 2.0 1,860 5.2
Median 42.0 42.0
Sex
Male 19,848 79.8 16,631 46.9
Female 5,015 20.2 18,845 53.1
Race/ethnicity
Non-Hispanic white 17,704 71.2 20,553 57.9
Non-Hispanic black 2,420 9.7 5,305 15.0
Hispanic 3,823 15.4 5,028 14.2
Asian 730 2.9 4,447 12.5
American Indian orAlaska Native 186 0.7 143 0.4
Education completed at enrollment
Below high school 1,375 5.5 4,165 11.7
High school 6,337 25.5 5,075 14.3
Some college 7,746 31.2 6,549 18.5
College or graduate 9,318 37.5 19,520 55.0
Unknown 87 0.3 167 0.5
Household income in 2002, $
<50,000 5,939 23.9 11,847 33.4
50,000 to<150,000 15,399 61.9 14,249 40.2
150,000 1,594 6.4 5,113 14.4
Unknown 1,931 7.8 4,267 12.0
Smoking status at enrollment
Current 4,464 18.0 5,070 14.3
Former 6,600 26.5 8,489 23.9
Never 13,728 55.2 20,313 57.3
Unknown 71 0.3 1,604 4.5
Any medical condition at enrollmenta
Yes 5,383 21.7 8,602 24.2
No/unknown 19,480 78.3 26,874 75.8
Residence since September11, 2001
NewYork state 18,171 73.1 26,721 75.3
Any of the other10 states 4,446 17.9 4,361 12.3
Both 2,246 9.0 4,394 12.4
Exposure level at WTC sites in rescue/recovery workersb
Low 6,057 24.4 NA
Intermediate 6,208 25.0 NA
Moderate high 5,866 23.6 NA
(Continued )
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A significantly reduced SIRwas observed for lung cancer
during the same follow-up period (#observed 42, SIR 0.69,
95% CI 0.50–0.93). One mesothelioma case was reported.
When the analyses were limited to the 18,171 NYS
residents, SIRs remained significantly elevated for prostate
(#observed 165, SIR 1.48, 95% CI 1.27–1.73), thyroid
(#observed 27, SIR 1.87, 95% CI 1.24–2.73), and skin
melanoma (# observed 28, SIR 1.63, 95%CI 1.08–2.35) and
were depressed for lung cancer (#observed 29, SIR 0.70,
95% CI 0.47–1.00).
When the analyses were further limited to NYC
residents, the SIR became significantly elevated for kidney
cancer (#observed 19, SIR 1.82, 95% CI 1.08–2.88), while
other SIRs remained the same.
Cancer Incidence Among Non-RRWs
A total of 992 first primary incident cancer cases were
identified among 35,476 non-RRWs, with an accumulated
171,901 person-years of follow-up. Median age at diagnosis
was 59 years (range: 7–99 years); two cancers were
diagnosed in persons <20 years old.
Cancer incidence for all sites combined (Table II) among
non-RRW was also significantly greater than the reference
population during the follow-up period from 2007 through
2011 (SIR¼ 1.08, 95% CI 1.02–1.15). Four of the 24 cancer
siteswere significantly elevated: prostate (#observed 196, SIR
1.27, 95% CI 1.10–1.46), skin melanoma (#observed 44, SIR
1.54, 95% CI 1.12–2.07), female breast (#observed 187,
SIR 1.34, 95% CI 1.15–1.55), and non-Hodgkin’s lymphoma
(#observed¼ 56, SIR¼ 1.49, 95% CI 1.13–1.93).
A significantly reduced SIR was also observed for lung
cancer during the same follow-up period (#observed 67, SIR
0.69, 95% CI 0.54–0.88). One mesothelioma case was
reported among non-RRW.
In the subgroup of 26,721 non-RRWwho had been NYS
residents since 9/11, SIRs remained significant for female
breast (#observed 150, SIR 1.32, 95% CI 1.12–1.55) and
non-Hodgkin’s lymphoma (#observed 44, SIR 1.52, 95% CI
1.11–2.04). SIRs for prostate cancer and skin melanoma
became non-significant. When further limited to NYC
residents compared to the NYC population, SIRs for the
four cancer sites remained significantly elevated.
Internal Comparisons by Level of
Exposure Among RRWs
Table III shows adjusted hazard ratios (aHR) for
selected cancers among RRW, adjusting for baseline
characteristics and enrollment source. Compared with the
lowest WTC exposure level, hazard ratios at each exposure
quartile were not significantly elevated for all sites-combined
or any site-specific cancer. However, urinary bladder cancer
was significantly associated with increasedWTC exposure in
the log transformation (aHR 2.18, 95% CI 1.10–4.34,
P¼ 0.0259), while the dose-response trend for urinary
bladder cancer using the original WTC exposure score was
not (aHR 1.03, 95% CI 0.99–1.05, P¼ 0.1098). No
significant dose-response trend was observed for hemato-
logic cancers among RRWs.
In a sub-analysis of kidney cancer amongRRWswhowere
NYC residents, there was no significant dose-response trend
associated with kidney cancer and WTC exposure levels.
Internal Comparisons by Level of
Exposure Among Non-RRWs
Table IV shows aHR for selected cancers among non-




Enrollees not involved in rescue/recovery
(non-RRW) (n¼ 35,476)
# % # %
High 6,039 24.3 NA
No/unknown 693 2.8 NA
9/11exposure level in enrollees not involved in rescue/recoveryb
Low NA 2,537 7.2
Intermediate NA 14,981 42.2
Moderate high NA 13,444 37.9
High NA 4,226 11.9
Unknown NA 288 0.8
WTCHR,World Trade Center Health Registry; NA, not available.
aAny history of heart disease, hypertension, angina, heart attack, stroke, diabetes, or emphysema reported at enrollment.
bSee Supplemental Tables I and II for explanation.
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of enrollment. There was a significant dose-response trend
for melanoma in relation to exposure (aHR 1.53, 95% CI
1.04–2.23, P¼ 0.0300), although the risks at the individual
exposure levels were not statistically significant. No
significant dose-response trend was observed for other sites.
Localized Cancer
Proportions of localized cancer in the NYS general adult
population were 84.7% (55,097/65,026) for prostate, 68.0%
(9,871/14,508) for thyroid, and 63.0% for female breast
cancer. We observed similar proportions of localized cancer
for prostate cancer (89.0%, 138/155), thyroid cancer (52.0%,
14/27), and female breast cancer (65.6%, 21/32) among
RRWs who were NYS residents since 9/11 (P> 0.05,
respectively). We further observed similar proportions of
localized cancers among non-RRWs who were NYS
residents since 9/11: 81.4% (96/118) for prostate, 79.4%
(27/34) for thyroid, and 64.8% (94/145) for female breast
cancer. None of these proportions was significantly different
from those of the NYS general population (P> 0.05).
DISCUSSION
We observed a statistically significant excess incidence
of total cancers among workers engaged in rescue/recovery
operations between 9/11/2001 and 7/31/2002, and non-RRW
survivors. Prostate cancer and malignant melanoma of the
skin were significantly elevated in both populations, with
prostate cancers contributing substantially to the total excess
TABLE II. Standardized Incidence Ratio (SIR) of First Primary Cancer Site Among Eligible Enrollees Using the New York State Population Rate as
Reference, 2007^2011 (N¼ 60,339)
Rescue/recovery workers (RRW) (N¼ 24,863)
Enrollees not involved in rescue and recovery
(non-RRW) (N¼ 35,476)
Site (SEER recode)b No. observed No. expected SIRa (95% CI) No. observed No. expected SIRa (95% CI)
All sites combined 685 617 1.11 (1.03^1.20) 992 916 1.08 (1.02^1.15)
Oral cavity and pharynx (20010^20100) 16 20 0.80 (0.46^1.30) 16 22 0.73 (0.42^1.19)
Esophagus (21010) 10 8 1.29 (0.62^2.38) 7 9 0.80 (0.32^1.65)
Stomach (21020) 9 10 0.89 (0.41^1.68 10 16 0.61 (0.29^1.12)
Colorectal (21041^21052) 47 51 0.93 (0.68^1.24) 74 75 0.98 (0.77^1.23)
Liver and intrahepatic bile duct (21071^21072) 13 15 0.86 (0.46^1.46) 27 19 1.41 (0.93^2.05)
Pancreas (21100) 10 14 0.70 (0.34^1.29) 22 22 1.02 (0.64^1.54)
Larynx (22020) 5 7 0.55 (0.15^1.42) 9 8 1.18 (0.54^2.25)
Lung and bronchus (22030) 42 61 0.69 (0.50^0.93) 67 97 0.69 (0.54^0.88)
Melanoma of the skin (25010) 37 25 1.49 (1.05^2.06) 44 29 1.54 (1.12^2.07)
Female breast (26000) 48 39 1.22 (0.90^1.61) 187 140 1.34 (1.15^1.55)
Corpus uterus and NOS (27020, 27030) 8 10 0.82 (0.35^1.62) 37 36 1.03 (0.72^1.41)
Ovary (27040) 5 5 0.80 (0.16^2.33) 13 14 0.95 (0.51^1.63)
Prostate (28010) 223 156 1.43 (1.25^1.63) 196 154 1.27 (1.10^1.46)
Testis (28020) 7 8 0.92 (0.37^1.91) 6 5 1.12 (0.41^2.43)
Urinary bladder (29010) 30 27 1.10 (0.74^1.57) 30 34 0.89 (0.60^1.27)
Kidney and renal pelvis (29020) 35 26 1.35 (0.94^1.88) 36 30 1.20 (0.84^1.66)
Brain and other nervous system (31010,31040) 7 9 0.77 (0.31^1.59) 15 11 1.32 (0.74^2.18)
Thyroid (32010) 37 21 1.79 (1.26^2.47) 48 39 1.23 (0.91^1.64)
Hodgkin’s lymphoma (33011^33012) 8 5 1.79 (0.77^3.53) 5 5 0.92 (0.30^2.14)
Non-Hodgkin’s lymphoma (33041^33042) 27 29 0.94 (0.62^1.37) 56 38 1.49 (1.13^1.93)
Multiple myeloma (34000) 12 9 1.35 (0.70^2.36) 9 13 0.67 (0.31^1.28)
Leukemia (35011^35043) 16 17 0.95 (0.54^1.54) 18 22 0.81 (0.48^1.29)
Soft tissue including heart (24000) 5 5 0.67 (0.14^1.95) 5 6 0.33 (0.04^1.20)
Mesothelioma (36010) 5 5 1.02 (0.03^5.68) 5 5 0.77 (0.02^4.28)
WTCHR,World Trade Center Health Registry; CI, confidence interval.
P-value< 0.05.
aAdjusted for age, gender, race/ethnicity, and study years.
bNot all of the specific cancer sites were presented. Therefore, the number of all cancer sites combined is greater than the sum of specified cancer sites in the
table.
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TABLE III. Risk of First Primary Cancer as a Function of WTC Exposure Among Rescue/Recovery Workers (RRW) With Known WTC Exposure













All sites combined Low (Q1) 177 29,304 Ref
Intermediate
(Q2)
171 30,212 1.03 0.83^1.27
Moderate high
(Q3)
162 28,538 1.08 0.87^1.35
High (Q4) 147 29,487 1.13 0.89^1.44
Continuous 1.00 0.997^1.01
Logc 1.12 0.97^1.28
Lung and bronchus (22030) Q1 12 29,304 Ref
Q2 8 30,212 0.71 0.29^1.77
Q3 15 28,538 1.53 0.69^3.43
Q4 7 29,487 0.78 0.28^2.16
Continuous 1.00 0.97^1.03
Logc 1.13 0.67^1.94
Melanoma of the skin (25010) Q1 10 29,304 Ref
Q2 6 30,212 0.73 0.26^2.07
Q3 9 28,538 1.16 0.43^3.09
Q4 10 29,487 1.18 0.42^3.34
Continuous 1.01 0.98^1.03
Logc 1.05 0.59^1.89
Female breast (26000) Q1 21 10,383 Ref
Q2 13 6,870 0.96 0.46^1.97
Q3 10 4,953 1.16 0.52^2.62
Q4 3 1,454 1.70 0.49^5.98
Continuous 1.02 0.98^1.05
Logc 1.16 0.65^2.05
Prostate (28010) Q1 50 18,921 Ref
Q2 61 23,342 1.17 0.80^1.71
Q3 49 23,585 0.99 0.66^1.49
Q4 54 28,034 1.25 0.82^1.89
Continuous 1.01 0.995^1.02
Logc 1.17 0.92^1.49
Urinary bladder (29010) Q1 0 29,304 NA
Q2 10 30,212 Ref
Q3 10 28,538 1.21 0.50^2.94
Q4 7 29,487 0.87 0.31^2.44
Continuous 1.03 0.995^1.05
Logc 2.18 1.10^4.34
Thyroid (32010) Q1 9 29,304 Ref
Q2 9 30,212 0.98 0.38^2.52
Q3 8 28,538 0.93 0.34^2.52
Q4 11 29,487 1.35 0.50^3.64
Continuous 1.00 0.97^1.02
Logc 1.08 0.61^1.92
Hematological cancerb (35011^35043, 33041,
33042, 33011^33012, 34000)
Q1 16 29,304 Ref
Q2 14 30,212 0.85 0.41^1.77
(Continued )
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of cancer across all sites. Thyroid cancer was significantly
elevated only in RRW, while breast cancer and non-
Hodgkin’s lymphoma were significantly elevated only in
non-RRW. Lung cancer in both populations was significantly
below expectation, by about 30%.
These findings utilize cancer cases diagnosed from 2007
through 2011, and thus, extend our earlier work [Li et al.,
2012] by 3 years, allowing the possibility of observation of
cancerswith longer latency periodswithin a populationwhose
background cancer rates in general are rising due to aging.
Excess prostate and thyroid cancers in this cohort were also
observed during 2007–2008 [Li et al., 2012] among RRWbut
not among non-RRW. A significant excess of multiple
myeloma among RRW in 2007–2008 was not sustained in
2007–2011. Excess breast cancer and non-Hodgkin’s lym-
phoma are new findings among non-RRW not seen in the
period of 2007–2008.
Although no comprehensive exposure measurements
are available for this cohort, numerous known and possible
carcinogens were identified in air and dust at the WTC site
and throughout lower Manhattan [NIOSH, 2011, 2012].
These included asbestos and silica, metals such as cadmium
and lead, PAH, dioxins, PCBs, and benzene [Wallingford
and Snyder 2001; Lioy et al., 2002; McKinney et al., 2002;
Edelman et al., 2003]. Intense and prolonged respiratory
exposures to these dusts among RRW were likely, and
numerous epidemiological studies have consistently found
strong associations with early development of non-malignant
respiratory diseases including asthma [Brackbill et al., 2009;
Perlman et al., 2011]. Furthermore, potential exposures for
rescue/recovery workers may have been exacerbated by fires
that burned at the WTC site for months [Lioy et al., 2002], as
well as by carcinogenic products of combustion, and
pyrolysis products from burning building materials and
furnishings. Six weeks after the attacks, exposure to
polychlorinated dibenzo-p-dioxins and dibenzofurans
(PCDD/Fs) through soil, and inhalation was up to 2.6 orders
of magnitude higher in lower Manhattan than typical
background levels measured in mid-Manhattan and Brook-
lyn [Rayne, 2005]. Cadmium in particular, an established
carcinogen, has been associated with bladder cancer [Feki-
Tounsi and Hamza-Chaffai, 2014], and melanoma [Venza
et al., 2014], but inconsistently with prostate cancer
[Waalkes and Rehm, 1994; Sahmoun et al., 2005]. In the
present study, we observed a significant dose-response trend
for WTC exposure level and urinary bladder cancer among
RRW, and for skin melanoma among non-RRW, but not for
other cancers with a statistically significant excess. Thus, the
strength of the evidence for the elevated cancers being
causally related to WTC exposure is limited.
The new findings among non-RRW are interesting,
particularly the significant excess incidence of non-Hodgkin’s
lymphoma (SIR 1.49, 95% CI 1.13–1.93). In addition, hazard
ratios were greater in each of the three higher exposure groups
in comparison with the lowest (reference) exposure, ranging
from 1.37 to 1.84, although none were statistically significant,
possibly due to the small number of total cases (54) distributed
among four exposure levels.Anumber of occupational studies
reported a significant elevation of non-Hodgkin’s lymphoma
risk in persons with probable occupational exposure to
benzene [Smith et al., 2007]. In view, however, of the














Q3 12 28,538 0.77 0.36^1.68
Q4 17 29,487 1.11 0.52^2.37
Continuous 1.00 0.99^1.03
Logc 1.04 0.66^1.64
Non-Hodgkin’s lymphoma (33041, 33042) Q1 9 29,304 Ref
Q2 4 30,212 0.42 0.13^1.38
Q3 5 28,538 0.57 0.18^1.78
Q4 7 29,487 0.89 0.29^2.73
Continuous 1.00 0.97^1.03
Logc 0.91 0.45^1.83
NA, not available; Ref, referent.
P-value¼ 0.0259.
aCox proportional hazards modeling, adjusted for age at the beginning of the follow-up period, race /ethnicity, sex, household income in 2002, education,
source of enrollment, smoking, and other medical conditions at enrollment.
bIncluded leukemia, Hodgkin’s and non-Hodgkin’s lymphomas, andmultiple myeloma.
cLog (natural) transformation of the actual WTC exposure scores.
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TABLE IV. Risk of First Primary Cancer as a Function of WTC Exposure AmongThose Not Involved in Rescue/Recovery (Non-RRW) With













All sites combined Low (1) 65 12,341 Ref
Intermediate (2) 399 72,495 0.95 0.72^1.23
Moderate high (3) 403 65,294 1.03 0.79^1.35
High (4) 115 20,385 0.86 0.63^1.17
Trend (1^4) 0.99 0.91^1.07
Female breast (26000) 1 14 5,373 Ref
2 85 38,739 0.83 0.47^1.47
3 68 35,118 0.68 0.38^1.21
4 19 11,456 0.60 0.30^1.21
Trend (1^4) 0.84 0.69^1.01
Hematological cancerb (35011^35043, 33041,
33042, 33011^33012, 34000)
1 6 12,341 Ref
2 33 72,495 0.83 0.34^2.01
3 35 65,294 0.93 0.38^2.26
4 12 20,385 0.89 0.32^2.45
Trend (1^4) 1.02 0.78^1.33
Lung and bronchus (22030) 1 2 12,341 Ref
2 30 72,495 1.64 0.39^7.03
3 26 65,294 1.78 0.42^7.60
4 8 20,385 1.15 0.24^5.58
Trend (1^4) 0.96 0.70^1.29
Melanoma of the skin (25010) 1 2 12,341 Ref
2 13 72,495 1.51 0.34^6.77
3 20 65,294 2.66 0.60^11.72
4 7 20,385 3.28 0.66^16.28
Trend (1^4) 1.53 1.04^2.23
Non-Hodgkin’s lymphoma (33041, 33042) 1 2 12,341 Ref
2 19 72,495 1.37 0.31^5.96
3 25 65,294 1.84 0.43^7.94
4 8 20,385 1.68 0.34^8.17
Trend (1^4) 1.18 0.84^1.66
Prostate (28010) 1 16 6,967 Ref
2 75 33,756 0.89 0.51^1.54
3 87 30,176 1.02 0.58^1.77
4 17 8,928 0.69 0.34^1.40
Trend (1^4) 0.96 0.80^1.15
Thyroid (32010) 1 1 12,341 Ref
2 20 72,495 3.49 0.47^26.22
3 24 65,294 4.18 0.56^31.35
4 3 20,385 1.97 0.20^19.21
Trend (1^4) 1.08 0.74^1.56
Urinary bladder (29010) 1 2 12,341 Ref
2 15 72,495 1.05 0.23^4.77
3 10 65,294 0.79 0.17^3.70
4 2 20,385 0.41 0.06^3.10
Trend (1^4) 0.74 0.46^1.19
NA, not available; Ref, referent.
P-value¼ 0.0300.
aCox proportional hazards modeling, adjusted for age at the beginning of the follow-up period, race/ethnicity, sex, household income in 2002, education, source of
enrollment, smoking, and other medical conditions at enrollment.
bIncluded leukemia, Hodgkin’s and non-Hodgkin’s lymphomas, and multiple myeloma.
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factors forNHL, including immunosuppression and infectious
agents (e.g., Epstein–Barr virus) [M€uller et al., 2005], the
findings from this study need to be further studied with more
cases in a longer follow-up period.
Strengths of this study include linkage with cancer
registries in states that are estimated to include at least 91%
of WTCHR enrollees, and the large sample size that
facilitated internal comparisons to examine whether any of
the cancers with higher than expected incidence were
associated with higher levels of exposure. Inclusion of non-
RRW provided an opportunity for assessment of risks in two
distinct populations with different types of exposure
opportunities. Furthermore, despite lack of objective expo-
sure measurements, we were able to construct robust
exposure categories using extensive exposure history data
(intensity and duration) from the baseline survey.
An important study limitation is our inability to
distinguish cancers detected because of increased monitoring
and screening of this population. This especially affects the
two most prominent site-specific findings, prostate, and
thyroid cancers, for which excessive medical screening or
early detection may have resulted in an increase in incidence
[Welch and Black, 2010; Brito and Davies, 2014; Davies and
Welch, 2014]. Although, no significant differences were
found in the proportion of localized (early stage) cancers
between our study sample and the NYS population, the
contrast between the significantly elevated SIR of 1.34 for
female breast cancer among non-RRW with the non-
significant adjusted hazard ratios below 1.0 in higher versus
lower exposed sub-groups may be due to our inability to
control for early cancer detection activities in these data such
as number of examinations, use of advanced diagnostic
imaging, or medical examinations leading to unintended
cancer detection.
There are other limitations as well. It is likely that
10 years of follow-up is an insufficient latency period for
some cancers. The small number of cases for some cancers
due to relatively short follow-up period may also affect the
stability of SIRs. The significant SIR for kidney cancer, when
the study population was restricted to NYC residents, might
have resulted from the 46% reduction in the number of cases.
Further work is required to determine the etiologic
significance of this observation.
Also, we lacked occupational histories for enrollees who
may have been exposed to hazardous materials prior to 9/11.
This is especially true for firefighters, because employment in
firefighting-related occupations has repeatedly been sug-
gested as a risk factor for malignant skin melanoma, prostate,
bladder cancer, multiple myeloma, non-Hodgkin’s lym-
phoma, and kidney cancer [LeMasters et al., 2006; Bates
2007; Daniels et al., 2014; Tsai et al., 2015]. The SIR results
may be biased by residual confounding because there
are usually many other differences between the exposed
population and the general population besides age, sex, and
race/ethnicity [Rothman and Greenland, 2008]. For example,
smoking is a well-known risk factor for lung cancer, and
smoking prevalence in 2003–2004 was about 18% for RRW
and 14% for non-RRW, lower than the 19.9–21.6% in NYS
adult population in 2003–2004 [NYSDH, 2006]. Therefore,
the significant deficit of lung cancer seen in both groups may
be due in part to the lower smoking rate in our study
population. In addition, we lack information on some well-
known risk factors for cancer such as ultraviolet (UV) light
exposure [Armstrong and Kricker, 2001], reproductive
patterns [Althuis et al., 2005], and family history of cancer.
Lastly, self-reported exposures could not be verified and were
subject to recall, and reporting biases. However, given that
exposure data were collected before the outcome cancer was
diagnosed, the influence of recall and reporting biases on
cancer outcomes should be minimal.
CONCLUSIONS
In this extended follow-up study, excess incidence of
prostate and thyroid cancers continued among RRW while
small but statistically significantly higher rates than expected
were found for skin melanoma in both populations, and
female breast cancer and non-Hodgkin’s lymphoma among
non-RRW. Only for lung cancer was there a significantly
lower rate. The increased incidence in most of these cancers
lacked support from internal comparisons to examine
whether there was an association with magnitude of
exposure. Even though a significant dose-response trend
associated with melanoma among non-RRW was observed,
the absence of information on a major confounder, that is,
UV light exposure before and after 9/11 makes meaningful
interpretation of causality between WTC exposure and the
cancer difficult. Despite the limitations of the study, our
findings show some evidence of increased risk of cancer
among WTC exposed populations, yet they need to be
substantiated by additional follow-up studies as the latency
period from a potential WTC exposure increases. Longer
term follow-up could be of direct value in describing the
magnitude of any differences seen in comparison to the
general population, and whether they might be related to
WTC exposure during 9/11 and its aftermath.
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